Overview: initial and long-term management of gastro-oesophageal reflux disease

dc.contributor.authorDent, J.
dc.contributor.authorTalley, N.
dc.date.issued2003
dc.descriptionArticle first published online: 4 MAR 2003
dc.description.abstractInitial management of gastro-oesophageal reflux disease aims to confirm a symptom-based diagnosis, to relieve symptoms, to reassure the patient as to the treatable nature of reflux disease, and to initiate risk management and healing of oesophagitis. The aims of long-term management include adequate control of symptoms, prevention of complications, and improvement of quality of life. Management options in terms of use of proton pump inhibitors are either daily therapy (maintenance), intermittent courses of therapy (for example, 4 weeks, then cease and observe), or on-demand therapy. This overview discusses the advantages and disadvantages of these different strategies for the management of reflux disease.
dc.description.statementofresponsibilityJ. Dent & N. J. Talley
dc.identifier.citationAlimentary Pharmacology and Therapeutics, 2003; 17(1):53-57
dc.identifier.doi10.1046/j.1365-2036.17.s1.10.x
dc.identifier.issn0269-2813
dc.identifier.issn1365-2036
dc.identifier.urihttp://hdl.handle.net/2440/56125
dc.language.isoen
dc.publisherBlackwell Publishing Ltd
dc.rights© 2003 Copyright Blackwell Publishing Ltd
dc.source.urihttps://doi.org/10.1046/j.1365-2036.17.s1.10.x
dc.subjectHumans
dc.subjectGastroesophageal Reflux
dc.subjectTreatment Failure
dc.subjectLong-Term Care
dc.subjectRisk Factors
dc.subjectDecision Making
dc.subjectRisk Management
dc.subjectProton Pump Inhibitors
dc.titleOverview: initial and long-term management of gastro-oesophageal reflux disease
dc.typeJournal article
pubs.publication-statusPublished

Files